Innovate UK

StimOxyGen is a biotechnology company focused on developing innovative, pH-responsive nanoparticles. These nanoparticles are designed to generate oxygen in hypoxic (low oxygen) tumors, enhancing the effectiveness of cancer treatments like radiotherapy and chemotherapy. The company's core technology involves a nanoparticle formulation that dissolves in the low pH environment of tumors, transiently producing oxygen and thereby maximizing the therapeutic effects of radiotherapy.

Lant Medical is a health technology company specializing in the development of non-antibiotic treatments for Helicobacter pylori (H. pylori) infections. Their innovative therapy targets the root cause of the infection and its associated symptoms, providing an effective monotherapy or complement to existing treatments. This enables healthcare professionals to manage H. pylori infections more efficiently.

Lant Medical is a health technology company specializing in the development of non-antibiotic treatments for Helicobacter pylori (H. pylori) infections. Their innovative therapy targets the root cause of the infection and its associated symptoms, providing an effective monotherapy or complement to existing treatments. This enables healthcare professionals to manage H. pylori infections more efficiently.

Circadacare specializes in improving the lives of residents and staff in care environments through innovative technology. Their solutions focus on enhancing wellness, promoting autonomy, reducing falls, and tracking behaviors using circadian lighting and advanced AI monitoring.

EnrichMyCare is a technology company that specializes in developing a personal health platform. This platform aims to centralize and streamline care coordination for children, improving communication between families and various healthcare, social care, and education providers. It enables instant sharing of records and remote monitoring of the child's welfare, simplifying the complex process of managing care. The platform also offers features to automate care pathways, monitor management plans, and ensure compliance with exercise and splinting programs. The ultimate goal is to accelerate care, enhance patient monitoring and engagement, prevent disabilities, and improve the overall care experience while reducing healthcare costs.

Mulder specializes in blockchain-based traceability solutions for the medical device industry. It develops a network platform that offers real-time visibility and traceability across the entire supply chain, from raw material sourcing to patient application. This enables healthcare providers and manufacturers to verify device provenance, ensure compliance, and enhance patient safety.

Axial3D specializes in 3D printing technology tailored for healthcare. It converts patient CT and MRI scan data into precise, personalized 3D models to enhance medical professionals' understanding of abnormalities, encourage innovative surgical techniques, and improve patient outcomes.

MediMusic is a health‑technology company that develops algorithmic music neuroscience solutions for medical and well‑being applications. Using artificial intelligence, it creates personalized playlists that lower heart rate and stimulate the vagus nerve, producing a positive physio‑endocrine response. The technology is designed to reduce stress and anxiety and to enhance the effectiveness of pain medication, and it is applied in contexts such as dementia care, anxiety treatment, and pain management.

LaennecAI is a clinical AI company specializing in chronic disease management solutions. It has developed a medical device, a digital stethoscope, which transforms modern smartphones into powerful diagnostic tools. The company's technology enables precise monitoring and analysis of respiratory and cardiac sounds, facilitating telemedicine, remote patient monitoring, and virtual wards. This ensures patients receive in-depth, reliable analysis and continuous care.

Reneural develops innovative, accessible technologies focused on improving cardiovascular disease treatment and management. Their flagship product is a wearable smart medical system designed to prevent blood clots in lower limbs, usable both clinically and at home.

Mulder specializes in blockchain-based traceability solutions for the medical device industry. It develops a network platform that offers real-time visibility and traceability across the entire supply chain, from raw material sourcing to patient application. This enables healthcare providers and manufacturers to verify device provenance, ensure compliance, and enhance patient safety.

Myogenes provides psychiatric tests, heredity cancer tests, and mental health mind maps.

Kaydiar is a medical device company focused on developing innovative offloading technologies for pressure injuries. Their product range includes orthotic devices, bed mattresses, wheelchair cushions, and prosthetic sleeves, all designed to reduce pressure on damaged skin or tissue, promoting cost-effective wound care.

Epitopea is a transatlantic biotechnology company focused on developing immunotherapies that target a novel class of tumor‑specific antigens. Using a proprietary pipeline that combines immunopetidomics, mass spectrometry, genomics and bioinformatics, the company identifies conserved, aberrantly expressed antigens hidden in cancer’s ‘junk’ DNA. These Cryptigen TSAs are shared across patients with the same cancer indication, allowing therapies to selectively eliminate malignant cells while sparing healthy tissue, with the goal of providing durable, low‑side‑effect treatments.

ScubaTx is a company focused on developing an advanced organ preservation system that utilizes the Persufflation method, a well-established technique aimed at enhancing organ transportation. By leveraging innovative software design, ScubaTx aims to provide significant cost savings for healthcare providers, thereby facilitating an expanded supply of viable organs for transplantation. The company’s technology is designed to protect and improve the condition of grafts during the preservation process, ultimately empowering clinicians worldwide to increase the availability of life-saving organs.

Theolytics Limited is a clinical-stage biotechnology company based in Oxford, United Kingdom, specializing in the development of oncolytic viral therapies to combat cancer. Founded in 2017, Theolytics utilizes a phenotypic screening platform that facilitates the discovery and development of effective, targeted therapeutic candidates designed for intravenous delivery. The company's innovative approach is aimed at creating category-changing cancer treatments that can address both solid and liquid tumors. In addition to advancing its internal pipeline of programs, Theolytics is also forming strategic partnerships to enhance and expedite the development of its therapeutic offerings, ultimately striving to provide innovative care options for patients.

Lentitek is a cell and gene therapy company developing gene therapies and gene-modified cell therapies to broaden access to cures. It focuses on increasing the production yields of lentiviral vectors through its platform, using a novel promoter and proprietary production methods. The approach aims to deliver substantially higher yields, potentially reducing manufacturing costs and improving scalability for healthcare providers delivering gene therapies.

SynaptixBio is a biotechnology company focused on developing innovative therapies for severe leukodystrophies, particularly targeting TUBB4a Leukodystrophy. By addressing the root causes of these conditions, SynaptixBio aims to provide potential curative treatments that could significantly disrupt existing treatment practices. The company is dedicated to translating groundbreaking research into transformative therapeutic options, specifically by altering the expression of a mutated gene responsible for the disease. Through its efforts, SynaptixBio seeks to deliver lifesaving solutions to those affected by this acute subset of leukodystrophies.

Naitive is a population health company that develops AI-enabled clinical pathways. It uses artificial intelligence, clinical data, digital interventions, and scalable computational capabilities to enhance chronic disease case-finding, treatment, and care coordination, aiming to transform patient care and reduce associated costs.

Siloton is a medical device company specializing in ophthalmology. It designs and develops diagnostic imaging devices, notably a portable optical coherence tomography system, coupled with cloud-based digital health tools to enhance patient care and prevent avoidable blindness.

BoobyBiome operates a microbiome research platform and develops probiotic supplements for infants with compromised microbiomes, including premature babies, to promote gut health and immune development by closely mirroring the beneficial bacteria found in breast milk.

Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.

ThirtyFiveBio is a biotechnology company developing novel genetically and pharmacologically validated protein modulators for treating severe gastrointestinal diseases.

KYMIRA is an e-commerce company specializing in smart garments and textiles designed to enhance athletic performance and recovery. The company develops innovative textiles that incorporate compression fabric, infrared technology, and sensors, which harness and recycle the energy of athletes. These products aim to improve performance, address chronic health issues, reduce injury risks, and enhance sleep quality. By providing data insights, KYMIRA enables athletes and sports enthusiasts to optimize their training and recovery processes.

Founded in London in 2016, LIfT BioSciences develops a proprietary platform for allogeneic innate immuno-cell therapy. Its Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) enables scalable production of Immunomodulatory Alpha Neutrophils (IMAN®s) from induced pluripotent stem cells (iPSCs), offering potential mono or combo therapies.

Medicsen is a start-up focused on healthcare innovation, primarily through the development of advanced technology solutions. A notable project is GlycSen, a needle-free drug delivery device aimed at providing a painless treatment option for individuals with insulin-dependent diabetes. This device integrates data from continuous glucose meters and user-inputted information, utilizing a learning algorithm to facilitate real-time monitoring. It features a chatbot interface that allows patients to easily track their condition, enhancing their ability to manage diabetes effectively. Through these innovations, Medicsen aims to improve the quality of life for those living with chronic diseases.

SleepCogni is developing a sleep aid technology that delivers a wind-down process to promote sleep. The device provides cognitive-behavioral therapy through biofeedback delivered via visual, auditory, and tactile cues and is triggered manually. It monitors physiological and behavioral sleep-related measures, including heart rate, mental alertness, skin temperature, and movement using sensors on the index finger, to guide users toward sleep initiation and improve sleep quality, addressing insomnia.

machineMD is a Swiss-based medical device company focused on innovating at the intersection of neuroscience and ophthalmology. It aims to significantly enhance the measurement of brain function, with the ultimate goal of enabling accurate, swift, and early diagnosis of brain disorders in primary and secondary care settings.

GaitQ Limited is a medical device company founded in 2019 and based in Oxfordshire, United Kingdom. It specializes in developing the GaitThaw device, which addresses the issue of gait freezing in individuals with Parkinson's disease. This small and portable device employs clinically proven sensory cues to assist patients in re-establishing the connection between the brain and body, thereby facilitating smoother walking. GaitQ aims to improve mobility and enhance the quality of life for those affected by this debilitating symptom of Parkinson's disease.

Graphene Trace is a healthcare technology company that specializes in preventing pressure ulcers, a common issue among wheelchair users and hospital patients. The company's core product is a smart, pressure-sensing fabric that continuously monitors pressure distribution, alerting users and caregivers in real-time to repositioning needs. This innovative solution enables early intervention, preventing pressure ulcers, and ensuring user comfort and affordability.

Renude operates a personalized skincare advice platform powered by AI. It aims to make reliable, tailored consultation accessible to all users. The company's team comprises dermatologists, formulation chemists, licensed aestheticians, data scientists, and machine learning engineers dedicated to developing dermatologist-approved AI skin advisors.

Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

Cortirio is a developer of portable brain imaging technology aimed at improving the diagnosis and treatment of traumatic brain injuries, which are a leading cause of death and disability among individuals under 40. The company designs portable scanners that utilize near-infrared imaging to deliver high-resolution, point-of-care medical imaging. These wearable devices provide critical information throughout the clinical pathway, facilitating automatic analysis and efficient data transfer. By equipping clinicians with rapid and accurate diagnostic tools, Cortirio enhances decision-making processes and improves care for patients suffering from brain injuries and strokes, ultimately aiming to reduce treatment times and prevent long-term disability or death.

Founded in 2017, SolasCure is a biotechnology company based in Wales, UK. It specializes in developing innovative hydrogel treatments for patients with chronic wounds. Its flagship product, Aurase, facilitates wound debridement, removing dead or infected tissue to enhance healing.

IXICO plc, established in 1995 and headquartered in London, specializes in providing data analytics services to the global biopharmaceutical industry. The company focuses on the collection, analysis, management, and reporting of data generated during clinical studies, with a particular emphasis on neurological diseases. IXICO's key technologies include Assessa, a digital platform for clinical decision support, and TrialTracker, a comprehensive imaging service workflow management system. The company's end-to-end imaging services are primarily applied in the fields of Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, cerebrovascular, and progressive supranuclear palsy diseases. IXICO's services are utilized to select patients for clinical trials, assess drug safety and efficacy, and for post-marketing surveillance. The company works with pharmaceutical companies, biotech firms, academia, and medical charities worldwide.

SökerData is a biotechnology company that specializes in research and data analysis solutions focused on disease-related datasets. The company has developed a data visualization platform designed to analyze biomarkers in clinical outcomes across various demographics. This platform provides researchers with essential features and tools for interpreting large datasets, facilitating early drug discovery. By enabling researchers to better understand the impact of biomarkers on different populations, SökerData supports informed decision-making and enhances the comprehension of disease outcomes in diverse demographic groups.

Concr is a mission-driven techbio company that uses established methods from astrophysics to predict patient outcomes and treatment response to cancer therapies. The approach enables iterative learning from fragmented data across the drug development and clinical journey, producing accurate multi-modal tumor models without relying on large, homogeneous datasets. Its cloud-native platform FarrSight supports computational simulation of clinical trials, prediction of therapeutic response and biomarkers, and standard bioinformatics analyses. Headquartered in London with a wholly owned subsidiary in Brisbane, Concr provides a cloud-based system that identifies optimal treatments for individuals, reduces resistance, and offers patient-specific progression insights and evidence-based treatment plans to guide proactive therapy.

Lucida Medical develops artificial intelligence–based healthcare technology to aid clinicians in the detection and diagnosis of cancer. Its platform analyzes imaging data from MRI and integrates imaging and multi-omics biomarkers and reporting tools to support cancer screening and diagnosis, with the aim of making detection more accurate, accessible, and faster while reducing costs. The company’s first product, Pi, is designed to assist in diagnosing prostate cancer using multiparametric or diffusion MRI and is a CE marked medical device.

Cyted specializes in digital diagnostic infrastructure, utilizing AI and innovative biomarkers for early disease detection. Its mission is to transform diagnostic methods, aiming for a world where diseases are prevented rather than treated.

At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.

Holly Health is a digital platform that translates health intentions into daily actions to support mental and physical wellbeing. The service delivers personalized habit coaching, chronic-condition support, and mental health resources through an AI-powered system designed to emulate a human health coach. It has been recognized by ORCHA as a top health app for weight management, stress reduction, wellness, and sleep. Since its international launch in summer 2021, Holly Health has pursued broad adoption and partnerships with primary care practices in the UK, numbering over 100 to date, with a mission to reach millions of users. The platform operates directly with individuals and through integration into primary care settings to help users sustain healthier behaviours and improve overall wellbeing.

Holly Health is a digital platform that translates health intentions into daily actions to support mental and physical wellbeing. The service delivers personalized habit coaching, chronic-condition support, and mental health resources through an AI-powered system designed to emulate a human health coach. It has been recognized by ORCHA as a top health app for weight management, stress reduction, wellness, and sleep. Since its international launch in summer 2021, Holly Health has pursued broad adoption and partnerships with primary care practices in the UK, numbering over 100 to date, with a mission to reach millions of users. The platform operates directly with individuals and through integration into primary care settings to help users sustain healthier behaviours and improve overall wellbeing.

CellRev is a biotechnology company specializing in process intensification for cell manufacturing. Its proprietary technology enables the transition from batch to continuous processing of adherent cells, increasing yields while reducing operating costs and capital expenditure.

Bioliberty is a medtech startup developing rehabilitation solutions and robotic gloves enabled by artificial intelligence to aid muscle recovery for degenerative and traumatic conditions. The company focuses on assistive robotics and rehabilitative devices to help patients with stroke, motor neuron disease, multiple sclerosis, rheumatoid arthritis, and osteoarthritis improve hand strength for daily tasks and live independently at home.

BelleVie is a provider of personal care services designed to support individuals in their daily lives while allowing them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. Its operating model is inspired by the Buurtzorg approach, emphasizing self-managing teams that foster meaningful relationships within the care ecosystem. BelleVie aims to create a society where every individual is valued and supported, promoting fulfilling careers within the care sector. To enhance its operations, the company utilizes a custom Wellbeing OS technology platform, which is underpinned by a subscription-based funding model.

SynaptixBio is a biotechnology company focused on developing innovative therapies for severe leukodystrophies, particularly targeting TUBB4a Leukodystrophy. By addressing the root causes of these conditions, SynaptixBio aims to provide potential curative treatments that could significantly disrupt existing treatment practices. The company is dedicated to translating groundbreaking research into transformative therapeutic options, specifically by altering the expression of a mutated gene responsible for the disease. Through its efforts, SynaptixBio seeks to deliver lifesaving solutions to those affected by this acute subset of leukodystrophies.

Spirecut is a MedTech company specializing in patented surgical instruments for treating carpal tunnel syndrome and trigger finger via ultrasound-guided surgery. Its technique avoids skin incisions and post-operative wounds, enabling patients to resume daily activities immediately.

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

Pathios Therapeutics is an early-stage biotech company based in Oxford, United Kingdom, focused on developing therapies for autoimmune diseases and cancer. Founded in 2017, the company specializes in creating small molecule inhibitors that target the pH-sensing G protein-coupled receptor GPR65. These inhibitors are designed to counteract the immunosuppressive effects of immune cells, such as tumor-associated macrophages, which are influenced by the acidic environment often found in tumors. By leveraging a deep scientific approach and human genetic insights, Pathios Therapeutics aims to generate novel therapeutics for advanced solid tumors and other unmet medical needs.

ThirtyFiveBio is a biotechnology company developing novel genetically and pharmacologically validated protein modulators for treating severe gastrointestinal diseases.

Founded in 2012, Stablepharma specializes in developing processes for vaccine stabilization. Its flagship product, Stablevax, enables precise dosage pre-loading into syringes at manufacture, eliminating wastage. The company's technology platform converts existing vaccines and diagnostics into thermostable products, addressing global cold chain challenges.

Jude is a healthcare company focused on addressing bladder-related issues and raising awareness about incontinence. It provides a range of bladder care solutions, including access to medical specialists who offer advice through social media platforms, virtual workshops, and private chat sessions. In addition to educational resources, Jude supplies health products designed to help individuals understand their conditions and manage them effectively. By promoting open discussions and providing expert guidance, Jude aims to empower individuals to lead leak-free lives and break the stigma surrounding bladder health.

AstronauTx focuses on restoring healthy function of astrocytes, a type of brain cell crucial for neuronal health and blood-brain barrier integrity. Its primary goal is to develop treatments targeting astrocyte dysfunction in dementias like Alzheimer's disease.

TherageniX specializes in gene therapy for tissue regeneration, focusing on orthopedic applications. The company's patented technology uses a non-viral delivery system to introduce specific genes, such as VEGF and BMP, into autologous bone marrow cells, enhancing their regenerative capacity. This process aids in tissue repair and regeneration, improving functional outcomes and reducing donor site trauma for patients with diseases, injuries, or age-related tissue damage.

NK:IO is a biotechnology company focused on developing natural killer cell-mediated immunotherapies for cancer. The company develops both cell therapies and small molecule therapeutics designed to target cancer and enhance the tumor-killing activity of natural killer cells.

Corryn is a biotechnology company specializing in the development of advanced wound care solutions. Its flagship product, Heals device, employs contactless technology to revolutionize the treatment of chronic and complex wounds.

Damibu Ltd is a technology company specialising in innovative digital solutions, particularly for healthcare and public sector organisations. They focus on creating platforms that simplify content management and distribution, enhancing communication efficiency. Notably, their product Damibu Feeds aids NHS groups in the UK by automating content sharing among GP surgeries, saving time and resources. Their approach emphasises user-friendly designs and interoperability, ensuring seamless integration with existing systems. Damibu's commitment to improving digital health communication is evident in their solutions, which aim to streamline processes, ensure content accuracy, and enhance patient engagement through reliable and accessible information dissemination.

Kalium Health Ltd is a medical technology company based in Cambridge, United Kingdom, that specializes in designing and manufacturing innovative tests for blood potassium concentration. Founded in 2018 and previously known as Kalium Diagnostics Ltd, the company focuses on patient-centric approaches to manage kidney disease, which significantly impacts healthcare costs. Kalium Health is developing a user-friendly finger-prick blood test that allows patients to monitor their potassium levels conveniently and affordably, addressing a critical risk associated with kidney disease. This technology aims to provide real-time, clinically actionable health insights into cardiorenal diseases, thereby transforming the standard of care for millions of patients. With a clear regulatory pathway and a targeted go-to-market strategy, Kalium Health is positioned to make a significant impact in the field of kidney care.

Autolomous develops pragmatic software solutions for cell and gene therapy manufacturers. Its platform, autoloMATE®, offers end-to-end solutions including resource scheduling, electronic batch records management, insights reporting, review, and release activities. The platform aligns with US FDA, EU EMA & UK MHRA guidance and is certified ISO 27001:2013 (information security), ISO 9001:2015 (quality management), and ISO 14001:2015 (environmental management).

Change My Face is an AI-powered face-changing technology used in healthcare, finance and skincare.

CalmBrain is a digital platform that provides psychological intervention for schools to assist students in managing their mental health, including anxiety, stress, and trauma.

Kids Speech Labs is a digital health company developing AI-driven solutions to manage and improve speech and language therapy services.

The Allergy Team assists families, companies, and educational institutions in managing food allergies.

Mumbli enhances hearing experiences by integrating wireless sound sensors into venues. Their IoT system monitors and reports on sound performance in real-time, benefiting individuals with hearing difficulties or noise sensitivities.

Juniver is a company focused on supporting individuals in long-term recovery from eating disorders through a neuroscience-based recovery program. It offers a platform that provides practical tools and habit-formation principles tailored to address disordered eating. By fostering a supportive community, Juniver enables users to manage cravings and ease urges, promoting sustainable recovery. The company's approach emphasizes specialized care and on-demand assistance, creating a comprehensive network for those seeking help in their journey towards healing.

Boost Innovations is a company focused on developing products specifically for women, with a particular emphasis on breast prostheses. Its primary offering is a specialized breast form designed to enhance comfort and usability for individuals who have undergone surgery. The prosthesis is engineered to remain securely in place when worn with post-surgery underwear, and it is suitable for various activities, including swimming and exercising. By prioritizing breathability and functionality, Boost Innovations aims to boost the confidence of its users and cater to their unique needs.

Life with Zeal a lifestyle brand that is revolutionizing the assisted living market.

Orthonika Limited, established in London in 2014, specializes in the manufacture of MenisciKnit, an innovative anatomical meniscus replacement designed to address the high unmet need for effective treatment of meniscus injuries. Its unique fiber-reinforced structure aims to restore full joint biomechanics and reduce the risk of osteoarthritis.

Tycho Medlink is to help people achieve new levels of rehabilitation through digital therapy.

Recreo VR operates a virtual reality (VR) platform that offers VR headsets, curated content, and support services. This platform enables residents, particularly those in care settings, to explore new experiences, revisit cherished memories, and connect with others through immersive VR environments.

Rescape Innovation Limited is a healthcare technology company based in Cardiff, United Kingdom, established in 2017. The company specializes in the design and manufacture of healthcare equipment, focusing on virtual reality distraction therapy. Rescape Innovation's technologies aim to address challenges in the healthcare sector, particularly in reducing anxiety and pain for patients while enhancing their overall experience. By leveraging virtual reality, the company seeks to improve communication and management of stress-related issues in clinical settings.

InsideOut specializes in mental health care and well-being support and is based in London. The company develops a health therapy platform delivered through an online application that uses an intelligent matching system to connect users with therapists, with the aim of breaking down social stigma and facilitating ongoing mental health care and positive well-being.

SyncVR Medical is an extended reality platform that uses virtual and augmented reality technologies to enhance healthcare. It provides a broad range of XR applications and access to third-party healthcare apps, enabling hospitals, patients, and medical professionals to improve treatment experiences and expand access to innovative digital care. The platform serves European and UK healthcare institutions, supporting numerous facilities and a growing network of developers that supply XR medical apps through its ecosystem.

Care Reality are a hybrid of EdTech and HealthTech building a new reality for learning.

Neu Health develops a smartphone-based clinical platform for personalized care in Parkinson's disease and dementia. The platform uses AI to monitor symptoms, optimize condition management, reduce clinician burden, and improve patient outcomes.

XR Therapeutics is a startup spun out of Newcastle University, offering healthcare services to support individuals with anxiety and phobias. It combines cognitive behavioral techniques with virtual reality simulations, recreating tailored scenarios in a controlled environment for effective treatment.

ScubaTx is a company focused on developing an advanced organ preservation system that utilizes the Persufflation method, a well-established technique aimed at enhancing organ transportation. By leveraging innovative software design, ScubaTx aims to provide significant cost savings for healthcare providers, thereby facilitating an expanded supply of viable organs for transplantation. The company’s technology is designed to protect and improve the condition of grafts during the preservation process, ultimately empowering clinicians worldwide to increase the availability of life-saving organs.

Lindus Health is a clinical research organization that specializes in managing end-to-end clinical trials for healthcare and biotechnology companies. The company offers services such as ethics and IRB submissions, trial monitoring, data management, biostatistics, regulatory affairs, and payor relations. Lindus Health employs an in-house team of clinicians and researchers to accelerate the clinical trial process using its proprietary software platform, Curebase OS, which automates workflows and reduces manual inefficiencies. The company also leverages real-world patient data for precise participant recruitment and smarter trial design, aiming to make clinical trials faster and more cost-effective while improving patient treatment outcomes.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Calla Lily Clinical Care is a women's health company focused on developing innovative drug delivery systems. Their proprietary platform, Callavid®, enables intravaginal drug delivery for various indications, including fertility and pregnancy support, prevention of recurrent bacterial vaginosis, hormone replacement therapy for menopause, and biomarker-based diagnostic tests.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Doctoria by Ozana is an AI-powered platform transforming communication in healthcare and law enforcement by breaking language barriers and streamlining documentation. Our solutions offer real-time medical interpretation, automated clinical note generation, and secure multilingual tools that enhance efficiency, compliance, and safety. Designed for scalability, Doctoria addresses critical gaps in high-pressure environments, thereby reducing costs and improving outcomes for hospitals, emergency responders, and public institutions.

Syndi is a digital health support recommendation platform that utilizes machine learning and digital phenotyping, with a primary focus on mental health. The company develops technology-driven solutions aimed at enhancing individuals' health by providing effective and accessible support. Syndi's platform employs passive smartphone data collection to gather moment-to-moment information about users, allowing it to deliver personalized and immediate care. This innovative approach not only facilitates connections between patients and healthcare providers but also measures the effectiveness of applications and digital services in treating invisible disabilities. Through its commitment to leveraging technology and research, Syndi seeks to improve healthcare outcomes for its users.

LightOx is a biotechnology company focused on developing innovative molecular tools and light-activated therapeutics for cancer treatment. The company offers a unique range of fluorescent probes that are smaller than existing commercial options, allowing for versatile use in imaging, therapeutics, and assay development. These probes can function as freely-moving agents within cells or be coupled with flexible linkers to provide specificity for various research applications. LightOx is dedicated to improving patient outcomes by creating targeted drug compounds that selectively eliminate tumor cells while minimizing damage to surrounding healthy tissues. This approach aims to enhance the efficiency of cancer treatment and contribute to better long-term health for patients.

PatientMpower specializes in remote monitoring solutions for patients with chronic diseases, particularly those with respiratory conditions. The company develops applications that integrate with devices such as spirometers and pulse oximeters, allowing patients to conduct health measurements from home. These devices connect to a smartphone application, which facilitates the transmission of real-time data to healthcare providers. This integration enhances the ability of healthcare workers to deliver high-quality care and monitor patient progress effectively. Additionally, PatientMpower’s solutions contribute to research efforts aimed at improving treatment methodologies, ultimately supporting better health outcomes for patients.

Myma Medical is a bright, cutting-edge start-up with a model to greatly improve the experiences of people who are having fertility issues.

FLY Mama is an online, trauma-informed integrated healthcare solution for pre- and postpartum well-being. The platform provides mental, emotional, and physical health support through an online membership, offering professional care across fertility journeys, pregnancy, and the postpartum period, including care for perinatal trauma and loss. It aims to function as an employee benefit program to support women during and after pregnancy, empowering them to navigate motherhood with greater confidence and well-being.

KYMIRA is an e-commerce company specializing in smart garments and textiles designed to enhance athletic performance and recovery. The company develops innovative textiles that incorporate compression fabric, infrared technology, and sensors, which harness and recycle the energy of athletes. These products aim to improve performance, address chronic health issues, reduce injury risks, and enhance sleep quality. By providing data insights, KYMIRA enables athletes and sports enthusiasts to optimize their training and recovery processes.

BelleVie is a provider of personal care services designed to support individuals in their daily lives while allowing them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. Its operating model is inspired by the Buurtzorg approach, emphasizing self-managing teams that foster meaningful relationships within the care ecosystem. BelleVie aims to create a society where every individual is valued and supported, promoting fulfilling careers within the care sector. To enhance its operations, the company utilizes a custom Wellbeing OS technology platform, which is underpinned by a subscription-based funding model.

Fallouh Healthcare specializes in the development and manufacturing of medical devices and AI-based software for cardiac surgery. Their products aim to enhance patient safety and streamline surgical workflows. Key offerings include systems for monitoring and protecting the heart during surgery, and AI-driven tools to detect and prevent complications like tamponade.

Healthera Ltd., established in 2015 and headquartered in Cambridge, UK, specializes in developing digital health solutions. Its flagship product, Healthera, is a pharmacy-integrated medication management app that offers automatic prescription reminders, smart labelling, scheduling, health condition tracking, and professional advice from pharmacists. Additionally, Healthera operates a healthcare marketplace that connects patients with local pharmacies and GPs, enabling faster medicine delivery and personalized care. The company partners with over 1000 pharmacies and Clinical Commissioning Groups (CCGs) across the UK, reaching over 20 million people. Healthera's technology is accredited by NHS Digital and aims to improve prescribing efficiency, patient experience, and reduce wastage within the NHS.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

Emm is a company focused on consumer health technology, developing tools to help individuals manage their health on their terms. It is building a menstrual cup with integrated biosensors designed to track biometric data and deliver personalized insights about menstrual health. The device aims to redefine period experiences by providing actionable information that helps users understand their health through technology and expert knowledge.

Brainstem is a DePIN to collect and utilise wearable health data. Our mission is to revolutionize healthcare and improve lives through remote screening, ongoing monitoring, digital treatment alternatives, and tools to share data with practitioners, researchers, and others. We are committed to building a network of users who are willing to share their data and embracing collaboration with smart minds to speed innovation. With our vision of being a 24/7 virtual health assistant specializing in sleep, mental, cardio, and neuro health, we are at the forefront of digital health.

52 North Health develops an AI-powered medical device for determining neutropenic sepsis risk in chemotherapy patients. Its portable finger-prick blood test measures neutrophil count and C-Reactive Protein (CRP) levels at home, enabling early detection and improved management of this fatal side effect.

Ascentys provides digital health business services.

The National Biofilms Innovation Centre (NBIC) serves as a collaborative hub uniting academia, industry, government, and public policy to address the challenges posed by biofilms, which significantly impact global economic activity across sectors such as food, health, shipping, clean water, and energy. Supported by funding from the BBSRC, Innovate UK, and Hartree Centre, NBIC's mission focuses on fostering a network for research and innovation that catalyzes partnerships with industry to drive breakthrough innovations. The Centre facilitates the exploration of unmet needs and the exchange of ideas through various initiatives, including roadmaps, workshops, and conferences. Additionally, NBIC is dedicated to nurturing the next generation of scientists through PhD and Post-Doc programs, alongside entrepreneurial training, aimed at enhancing their expertise and understanding of the commercial landscape while promoting the creation of new start-ups.

Enhanced Fertility is a digital health company that uses data, artificial intelligence, and remote diagnostics to improve fertility care. It aims to increase access to fertility treatment for the 1 in 6 couples globally facing infertility, with less than 2% currently able to access needed care. The company's platform helps fertility clinics make data-driven clinical decisions, from diagnosis to treatment, to enhance live birth rates. It streamlines the patient pathway, reducing the time to treatment from three years to just 30 days through at-home testing and AI-enabled care.